In the m-ITT SVR analysis, HCV genotype 3 individuals had an almost significant lower SVR rate in comparison to non-genotype 3 patients.
← all excerpts
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil.
1
—
—